Research Money spoke with Diane Gosselin, president and CEO of the biopharmaceutical research consortium CQDM, on how Canada can reinvigorate and build its biopharmaceutical sector after the pandemic.
Topic: domestic life sciences sector
The Short Report – August 4, 2021: Ottawa’s new biomanufacturing and life sciences strategy, a national startup job board, rural transit solutions, and more
Ottawa prepares for future pandemics with launch of life science strategy, CellCAN and CCRM launch a new cell and gene therapy institute to tackle gaps in training, a new fund dedicated to developing transit solutions for rural and remote communities, and more.